About the Authors
- Christopher F. Rider
-
Affiliation Airways Inflammation Research Group, Snyder Institute of Chronic Diseases, Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada
- Suharsh Shah
-
Affiliation Airways Inflammation Research Group, Snyder Institute of Chronic Diseases, Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada
- Anna Miller-Larsson
-
Affiliation AstraZeneca R&D Mölndal, Mölndal, Sweden
- Mark A. Giembycz
-
Affiliation Airways Inflammation Research Group, Snyder Institute of Chronic Diseases, Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada
- Robert Newton
-
* E-mail: rnewton@ucalgary.ca
Affiliation Airways Inflammation Research Group, Snyder Institute of Chronic Diseases, Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada
Competing Interests
AML is an employee of AstraZeneca. Research was supported by grants from AstraZeneca and GlaxoSmithKline (RN, MAG). The authors can confirm that Dr. Miller-Larsson’s employment by AstraZeneca does not alter their adherence to PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: CFR AML MAG RN. Performed the experiments: CFR SS. Analyzed the data: CFR SS RN. Contributed reagents/materials/analysis tools: AML. Wrote the paper: CFR SS AML MAG RN.